RPRX
Royalty Pharma plc
Revenue to net incomeLast 12 months
Key figures
| Metric | Last 12 months | 5-year CAGR |
|---|---|---|
| Revenue | $2.6B | +2.3% |
| Operating income | $1.5B | −0.5% |
| Net income | $672M | −4.6% |
| EPS | $1.53 | +6.2% |
Royalty Pharma plc
| Metric | Last 12 months | 5-year CAGR |
|---|---|---|
| Revenue | $2.6B | +2.3% |
| Operating income | $1.5B | −0.5% |
| Net income | $672M | −4.6% |
| EPS | $1.53 | +6.2% |